Sihuan Pharma Shareholders Approve Key Resolutions

Sihuan Pharmaceutical Holdings Group (HK:0460) has released an update.

Sihuan Pharmaceutical Holdings Group Ltd. successfully passed all resolutions during their Annual General Meeting on June 7, 2024, with overwhelming shareholder support. Key approvals included the adoption of audited financial statements, re-election of directors, and the reappointment of Ernst & Young as their Auditor. Additionally, shareholders granted the directors mandates to issue, deal with additional shares, repurchase shares, and extend authority on treasury shares transactions.

For further insights into HK:0460 stock, check out TipRanks’ Stock Analysis page.